Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Process-for-preparing-narasin

 Method of preparing a high-purity, virus safe, biologically active transferrin preparation
We claim: 1. A method of preparing a high-purity, virus-safe biologically active, transferrin ...


 Hydrolyzable resin composition and an antifouling coating composition containing the same
What is claimed is: 1. A method of preventing marine fouling which comprises applying to a surface ...


 Treatment for herpes virus
OF THE INVENTION According to the invention, I provide a composition for and method of use of such ...


 Microbicidal meta oxy- and thio-substituted phenylanilines
What is claimed is: 1. A compound of the formula I, including salts and metal complexes thereof ##ST...


 Synergistic microbiocidal composition containing a mixture of a bicyclic polyoxymethyleneoxazolidine and an acroloin/formaldehyde polycondensation product
We claim: 1. A microbiocidal composition comprising a synergistic mixture the first component of ...


 Substituted acyl derivatives of amino acids
OF THE INVENTION The invention in its broad aspects includes substituted acyl derivatives of amino ...


 Escherichia coliO-polysaccharide-protein conjugate vaccine
OF THE INVENTION The present invention relates to E. coli-protein conjugates for use in vaccines ...


 Milk production
What is claimed is: 1. The method of improving rumen acetate/propionate ratios and milk production ...


 Heterocyclic compounds, processes for their preparation and their use
We claim: 1. A compound of general formula (I): ##STR14## in which the amide function is in the 2 ...


 Virus insecticide compositions
What is claimed is: 1. A particulate insecticidal composition comprising a free-flowing particle ...


 Process for preparing narasin

Details
Inventors: Kastner, Ralph E.; Hamil, Robert L.;
Assignee: Eli Lilly and Company (Indianapolis, IN)
Primary Examiner: Shapiro; Lionel M.
Assistant Examiner:
Attorney, Agent or Firm: Morrison; Dwight E., Whale; Arthur R.

The new microorganism Streptomyces granuloruber, NRRL 12389 and the fermentation process for preparing narasin by submerged aerobic fermentation of this organism.

DETAILED DESCRIPTION The new microorganism of this invention is a biologically pure culture derived from a soil sample collected near the Surinam River, Surinam, South America.
The culture was given the number A-39912 for identification purposes.
Culture A-39912 is classified as Streptomyces granuloruber, based upon a simultaneous culturing of Streptomyces rubra; Streptomyces griseoruber; and Streptomyces griseoaurantiacus, using the methods and media recommended by Shirling and Gottlieb ["Methods of Characterization of Streptomyces species," Int.
Bull.
of Systematic Bacteriol.
16, 313-340 (1966)], along with certain supplementary tests.
Culture A-39912 was also compared with the description of Streptomyces longispororuber reported by Gerber, J.
Antibiot.
28, 194-199 (1975).
Culture A-39912 differs from Streptomyces rubra by producing granules, that is, crystals of undecylprodiginine, a purplish-red dye, by producing a purplish-red to black vegetative mycelium, and by reducing nitrate.
Culture A-39912 produces a red and gray aerial mycelium in contrast to the gray aerial mycelium of Streptomyces griseoruber.
The purplish-red to black vegetative mycelium produced by culture A-39912 also differs from the yellow brown to reddish orange vegetative mycelium of Streptomyces griseoruber.
Streptomyces griseoaurantiacus does not produce the distinctive purplish-red to black vegetative mycelium, as does culture A-39912.
Neither Streptomyces griseoruber nor Streptomyces griseoaurantiacus produces the purplish-red crystals of undecylprodiginine as does A-39912.
Thus, comparison of culture A-39912 with the above-named cultures shows significant differences.
Our culture is considered to be a new species and is described as Streptomyces granuloruber.
CHARACTERIZATION OF NARASIN-PRODUCING STRAIN Morphology Produces spiralled sporophores.
The spores are smooth as determined by electron microscopy and are oval to slightly cylindrical in shape.
The spores measure an average of 1.
3 .
mu.
m.
times.
2.
015 .
mu.
m with a range of 1



Related patents
  Reversible optical waveguide vapor sensor
Accordingly, it is an object of the invention to detect small amounts of a chemical in air and in other gases. Another object is to provide a device for such purpose ...
  Biotinidase-resistant biotinylated compound and methods of use thereof
This invention relates to biotinidase-resistant biotinylated compounds containing a chemical fragment having the structure: ##STR2## wherein R.sub.1 and R.sub.3 are ...
  Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
This invention provides a facile, efficient and reproducible method for recovering biologically active Shiga-like toxins from a sample using an affinity ligand ...
  Assays for shiga toxin and shiga-like toxins
OF THE INVENTION The present invention relates to a substantially pure antigenic or peptide protein related to Shiga toxin (ST) or Shiga-like toxins I or II (SLT-II, SLT...
  Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
OF THE INVENTION Histologic examination of colonic tissue has revealed no evidence of attachment of E. coli O157:H7 to bovine colonic tissue. The rumen appears to be ...
  Feline leukemia virus vaccines
OF THE INVENTION Any immunogenic FeLV protein may be expressed in baculovirus following the methods and techniques described here. For instance, the location and ...
  Resolution of D,L-dehydroproline
I claim: 1. A method for the preparation of L-3,4-dehydroproline comprising in combination the steps of: A. treating N-protected D,L-3,4-dehydroproline with R(+)-alpha-...
  Quaternary salts as hypoglycemic agents
OF THE INVENTION The hypoglycemic agents of the present invention are synthesized by the reaction of a suitable halide with the appropriate heterocyclic ring system, ...
  7-[.alpha.-(2-Aminomethyl-1-cyclohexenyl)-acetamido]-3-heterocyclic thiomethyl-3-cephem-4-carboxylic acids
We claim: 1. An acid having the formula ##SPC42## wherein R is ##SPC43## ##SPC44## or ##EQU1## or a nontoxic, pharmaceutically acceptable salt thereof. 2. The acid of ...
  Pasteurized therapeutically active protein compositions
What is claimed is: 1. A method of pasteurizing a composition comprising a thermally sensitive, therapeutically active protein selected from the group consisiting of ...

0.024

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved